Data analysis, clinical biostatistics and more.
Company founded in
Percent employees with university degree
Our team members are experts in biostatistics. Beyond that, we are experienced in project work, working on different infrastructures and with complex processes.
Staburo Client Segments
- Biotech, Medical Device companies, etc.
Temporally and spatially flexible
Experienced in pharma processes
Check out our latest news!
Staburo supported pegfilgrastim biosimilar development Together with Cinfa Biotech GmbH (now Mundipharma Biologics) and the University of Lucerne, Staburo recently published the first part of the results for Pelmeg, a pegfilgrastim biosimilar which is used for...
PD-L1 assay comparability study published Staburo supported the evaluation of the first multicentric analytical comparability study of PD-L1 expression in urothelial bladder cancer using four clinically developed immunohistochemistry assays. Statistical analyses...
R Shiny App for Standardized Detection of Outliers in Bioassay Development The availability of reliable and sensitive assays is an important building block in the production and quality control of biological products. In the development of such assays, unusual or...